Clinical updates, including trial initiations, enrollment status and data readouts and publications: AGTC, Alligator, Ampio, Amryt, Astrazeneca, Aztherapies, Brain Neurotherapy, Cellectar, Clearside, Enterome, Flexion, Intensity, Intra-Cellular, Leukemia & Lymphoma Society, Lipac, Merck, Myokardia, Neurosense, Octapharma, Regenxbio, Roche, Scholar Rock, Sinovac, Trillium, Viking.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acutus, Alkahest, Arches Research, Assure Holdings, Avacta, Cambus Medical, Co-Diagnostics, Confirm Biosciences, Cytosorbents, Diagnos, Diasorin, Fluidigm, Freudenberg Medical, Grifols, Inovio, Irhythm, Labcorp, Memed, Merit Medical, Neuronostics, Polarity TE, Qiagen, Roche Canada, Seegene, Thermo Fisher Scientific.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alkahest, Anges, Anheart, Aptorum, Astrazeneca, Auris, Aveo, Avidity, Biodesix, Biomica, Biontech, Briacell, Brickell, Canbridge, Catalent, Cheplapharm, CN, Cymerus, Daiichi Sankyo, Destiny, Exelixis, Exmceuticals, Glaxosmithkline, Grifols, Humanigen, Icanomab, Innovation, Inovio, Intravacc, Johnson & Johnson, Kite, Lineage Cell, Mab, Moderna, Mylan, NBE, Novavax, Pharmacyte, Pharmamar, Phoremost, Protalix, Recce, Redhill, Regenerx, Sanofi, Silence, Sporegen, Takeda, Vaxart, Vaxil, Vyne, Xtalpi, Zyversa.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Albireo, Allena, Astrazeneca, Athenex, Bayer, Bellus, Biomarin, BMS, Calliditas, Celularity, Clene, Compugen, Corbus, Cyclo, Goldfinch, HRA Pharma, Insmed, Kamada, Merck, Novartis, Radius, Sanofi, Savara, Silence, Spero, Strongbridge, Synairgen, Transgene, Translate Bio, Valneva, Verona.

The latest global regulatory news, changes and updates affecting biopharma, including: Abbvie, Allergan, Astrazeneca, Calvin Scott, Gedeon Richter, HRA Pharma, Nestle.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Roche.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 54gene, Ascyrus Medical, Cryolife, Ehave, Feinstein Institute, Illumina, Infosys, Kaleidoscope Innovation, Novacyt, Ocular Therapeutix, Organovo, Orthopaedic Innovation Centre, Precipio, T2 Biosystems.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Gelesis, Medmira.